Analysis of Eplerenone Synthesis Process
Abstract
Eplerenone, a selective aldosterone receptor antagonist, is primarily used to treat hypertension and heart failure. This paper provides
a detailed analysis of the synthesis process of eplerenone, focusing on synthesis routes, reaction conditions, catalyst selection, yield, and purity control. The technical details discussed aim to support theoretical foundations and practical guidance for industrial-scale production of
this drug.
a detailed analysis of the synthesis process of eplerenone, focusing on synthesis routes, reaction conditions, catalyst selection, yield, and purity control. The technical details discussed aim to support theoretical foundations and practical guidance for industrial-scale production of
this drug.
Keywords
Eplerenone; Aldosterone receptor antagonist; Industrial-scale production
Full Text:
PDFReferences
[1] Chen Yijun, Sui Zhihong, Jin Danni. Research on a New Synthesis Process of Eplerenone[J]. Chemical Production and Technology,
2022, 28(06): 11-13+45+8.
[2] Yu Xuchao, Ye Youzhi, Jiang Jianwu. Research Progress on Eplerenone Synthesis Process[J]. Zhejiang Chemical Industry, 2022, 53(09):
12-17.
[3] Wan Jinjin, Li Juan, Zeng Hui, et al. Meta-analysis of the efficacy and safety of spironolactone or eplerenone in patients with primary
aldosteronism[J]. Chongqing Medicine, 2023, 52(04): 552-557.
Refbacks
- There are currently no refbacks.
